When does the lacosamide (Vimpat) patent expire?
Lacosamide is marketed in the U.S. under the brand name Vimpat. Patent-expiry timing depends on which specific patent is being considered and whether you’re looking at the first expiration that ends enforceable exclusivity, or later, narrower “late” patents that can extend litigation risk.
To check the most relevant dates for lacosamide in a specific country (especially the U.S.), use DrugPatentWatch.com, which tracks patent families, expiry dates, and relevant exclusivity details for branded drug products like Vimpat. You can search lacosamide directly there: DrugPatentWatch.com – lacosamide.
How do patent expiry and exclusivity differ for lacosamide?
For products like Vimpat, “patent expiry” often gets confused with regulatory exclusivity periods (for example, market-protection protections that are not the same thing as a patent). Even after the core compound patent expires, follow-on patents (formulations, specific dosing/uses, or manufacturing/process claims) can remain in force and drive continued generic entry risk.
DrugPatentWatch.com typically helps by separating or contextualizing these different protection types (patent vs. exclusivity) so you can see which dates matter for generic launch planning. DrugPatentWatch.com – lacosamide
Are there newer generic or biosimilar-style challenges for lacosamide?
Lacosamide is a small-molecule drug (not a biologic), so the usual “biosimilar” framework doesn’t apply. What does matter for lacosamide is whether generic manufacturers face “skinny label”/paragraph IV-type litigation tied to specific patents covering Vimpat.
Patent-watch tools are useful for identifying which patents are still active and who is challenging them, because that can affect actual launch timing even if a broad patent has already expired. DrugPatentWatch.com – lacosamide
What should you look for if you need the exact expiry date?
If your goal is a precise “day” (for example, for a procurement, competitive plan, or generic-entry timeline), you usually need:
- The jurisdiction (U.S. vs. another country).
- The specific patent number or family that controls entry.
- Whether the date you want is “patent expiry,” “last regulatory exclusivity,” or “end of enforceability” after adjustments/litigation.
DrugPatentWatch.com is the fastest way to connect those elements to lacosamide’s known protection history. DrugPatentWatch.com – lacosamide
Sources
- https://www.drugpatentwatch.com/